Levocetrine

# Levocetrine ## Overview - **Classification**: Second-generation antihistamine, H1-receptor antagonist - **Mechanism**: Selectively antagonizes peripheral H1-receptors, inhibiting histamine-mediated allergic responses without significant anticholinergic or antiserotonergic effects. ## Primary Indications 1. **Seasonal Allergic Rhinitis** - Symptomatic relief of sneezing, rhinorrhea, pruritus, and ocular symptoms. 2. **Perennial Allergic Rhinitis** - Symptomatic relief of chronic nasal allergy symptoms. 3. **Chronic Idiopathic Urticaria** - Relief of pruritus and reduction in the number and size of hives. ## Adult Dosing ### Standard Dosing **Allergic Rhinitis (Seasonal, Perennial) & Chronic Idiopathic Urticaria** - **Dose**: **5 mg** - **Frequency**: Once daily - **Route**: Oral - **Special Considerations**: May take with or without food. ### Dose Adjustments - **Renal Impairment**: - CrCl 50-79 mL/min: **5 mg** once daily - CrCl 30-49 mL/min: **2.5 mg** once daily - CrCl 10-29 mL/min: **2.5 mg** every other day - CrCl < 10 mL/min or Hemodialysis: **Contraindicated** - **Hepatic Impairment**: No dose adjustment required for isolated hepatic impairment. - **Elderly Patients**: Dose adjustments based on renal function are generally recommended. ## Pediatric Dosing ### Neonates (0-6 months) - **Dose**: Not recommended - **Special Notes**: Safety and efficacy not established; contraindicated in infants 0-6 months. ### Infants/Toddlers (6 months to <2 years) - **Indication**: Allergic rhinitis, chronic idiopathic urticaria - **Dose**: **1.25 mg** (2.5 mL oral solution) - **Frequency**: Once daily - **Maximum**: **1.25 mg/day** - **Special Notes**: Use oral solution formulation. ### Children (2-5 years) - **Indication**: Allergic rhinitis, chronic idiopathic urticaria - **Dose**: **1.25 mg** (2.5 mL oral solution) - **Frequency**: Once daily - **Maximum**: **2.5 mg/day** (may be given as 1.25 mg BID if needed and tolerated) - **Special Notes**: Use oral solution formulation. ### Children (6-11 years) - **Indication**: Allergic rhinitis, chronic idiopathic urticaria - **Dose**: **2.5 mg** (tablet or 5 mL oral solution) - **Frequency**: Once daily - **Maximum**: **2.5 mg/day** ### Adolescents (12-18 years) - **Indication**: Allergic rhinitis, chronic idiopathic urticaria - **Dose**: **5 mg** (same as adult dose) - **Frequency**: Once daily - **Maximum**: **5 mg/day** ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to levocetirizine, cetirizine, or hydroxyzine. - **Absolute**: End-stage renal disease (CrCl < 10 mL/min) or hemodialysis. - **Absolute**: Infants 0-6 months due to lack of safety data. - **Absolute**: Children 6 months to 11 years with renal impairment (no dose recommendations). ### Common Adverse Effects - **Very Common (>10%)**: Somnolence (drowsiness), fatigue. - **Common (1-10%)**: Nasopharyngitis, dry mouth, pharyngitis, cough, headache. - **Serious but Rare**: Angioedema, anaphylaxis, seizures (especially with predisposing factors). ### Key Drug Interactions - **CNS Depressants (e.g., alcohol, sedatives, opioids)**: Increased CNS depression and psychomotor impairment. **Avoid concomitant use**. - **Ritonavir**: May increase levocetirizine exposure, potentially increasing side effects. Monitor for increased sedation. - **Theophylline**: Small decrease in levocetirizine clearance, generally not clinically significant. ## Monitoring & Follow-up - **Before Treatment**: Assess renal function (especially in elderly or high-risk patients). - **During Treatment**: Monitor for symptom relief and adverse effects, especially sedation. - **Clinical Signs**: Watch for excessive drowsiness, dizziness, or any signs of hypersensitivity. ## Clinical Pearls - 💡 **Timing**: Taking in the evening may mitigate potential daytime drowsiness. - 💡 **Alcohol**: Advise patients to avoid alcohol due to additive CNS depressant effects. - 💡 **Formulations**: Available as oral tablets and an oral solution, facilitating pediatric dosing. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.